Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Breast Neoplasms 695Neoplasms 613Prostatic Neoplasms 315Lung Neoplasms 308Colorectal Neoplasms 282Carcinoma, Non-Small-Cell Lung 254Pancreatic Neoplasms 178Carcinoma, Hepatocellular 168Stomach Neoplasms 139Multiple Myeloma 127Ovarian Neoplasms 120Melanoma 118Colonic Neoplasms 112Brain Neoplasms 108Hematologic Neoplasms 107Head and Neck Neoplasms 106Urinary Bladder Neoplasms 103Leukemia, Myeloid, Acute 102Esophageal Neoplasms 101Disease 100Uterine Cervical Neoplasms 89Neoplasm Metastasis 89Liver Neoplasms 88Rectal Neoplasms 85Lymphoma 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 83Endometrial Neoplasms 76Carcinoma, Renal Cell 73Leukemia 63Recurrence 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Hydatidiform Mole × 1 year × Clear all
NCT01008501 2026-04-23

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

Baylor College of Medicine

Active not recruiting
100 enrolled

Hydatidiform Mole

NCT07202728 2025-10-02

CN-HM-01

Obstetrics & Gynecology Hospital of Fudan University

Recruiting
1,489 enrolled

Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon âš¡